
Publications of J. Tatzelt
All genres
Journal Article (21)
1.
Journal Article
30 (10), pp. 2057 - 2070 (2011)
The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication. EMBO Journal 2.
Journal Article
94 (4 Sp. Iss.), pp. 457 - 464 (2010)
Synthesis of a GPI Anchor Module Suitable for Protein Post-Translational Modification. Biopolymers 3.
Journal Article
107 (1), pp. 218 - 229 (2008)
Green tea extracts interfere with the stress-protective activity of PrPC and the formation of PrPSc. Journal of Neurochemistry 4.
Journal Article
14 (9), pp. 994 - 1006 (2007)
Semisynthetic murine prion protein equipped with a GPI anchor mimic incorporates into cellular membranes. Chemistry & Biology 5.
Journal Article
341 (1), pp. 218 - 224 (2006)
Prion protein-related proteins from zebrafish are complex glycosylated and contain a glycosylphosphatidylinositol anchor. Biochemical and Biophysical Research Communications 6.
Journal Article
386 (11), pp. 1149 - 1155 (2005)
The polysaccharide scaffold of PrP 27-30 is a common compound of natural prions and consists of alpha-linked polyglucose. Biological Chemistry 7.
Journal Article
272 (Suppl. Suppl. 1), pp. 338 - 339 (2005)
Single molecule analysis of protein aggregation and prions by SIFT. FEBS Journal 8.
Journal Article
79 (12), pp. 7785 - 7791 (2005)
Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets. Journal of Virology 9.
Journal Article
64 (5), p. 441 - 441 (2005)
Single molecule analysis of protein aggregation and prions by sift. Journal of Neuropathology and Experimental Neurology 10.
Journal Article
280 (10), pp. 9320 - 9329 (2005)
Pathogenic mutations located in the hydrophobic core of the prion protein interfere with folding and attachment of the glycosylphosphatidylinositol anchor. Journal of Biological Chemistry 11.
Journal Article
280 (7), pp. 5137 - 5140 (2005)
A pathogenic PrP mutation and Doppel interfere with polarized sorting of the prion protein. Journal of Biological Chemistry 12.
Journal Article
92 (1), pp. 114 - 122 (2005)
Pathogenic mutations inactivate parkin by distinct mechanisms. Journal of Neurochemistry 13.
Journal Article
344 (3), pp. 839 - 853 (2004)
The structural transition of the prion protein into its pathogenic conformation is induced by unmasking hydrophobic sites. Journal of Molecular Biology 14.
Journal Article
11 (3), pp. 162 - 172 (2004)
Folding and misfolding of the prion protein in the secretory pathway. Amyloid-Journal of Protein Folding Disorders 15.
Journal Article
5 (6), pp. 426 - 436 (2004)
Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation. Traffic 16.
Journal Article
279 (7), pp. 5435 - 5443 (2004)
The C-terminal globular domain of the prion protein is necessary and sufficient for import into the endoplasmic reticulum. Journal of Biological Chemistry 17.
Journal Article
278 (47), pp. 47199 - 47208 (2003)
Inactivation of parkin by oxidative stress and C-terminal truncations - A protective role of molecular chaperones. Journal of Biological Chemistry 18.
Journal Article
278 (38), pp. 36139 - 36147 (2003)
Post-translational import of the prion protein into the endoplasmic reticulum interferes with cell viability - A critical role for the putative transmembrane domain. Journal of Biological Chemistry 19.
Journal Article
4 (5), pp. 313 - 322 (2003)
Inhibition of complex glycosylation increases the formation of PrPsc. Traffic 20.
Journal Article
278 (17), pp. 14961 - 14970 (2003)
Determinants of the in vivo folding of the prion protein - A bipartite function of helix 1 in folding and aggregation. Journal of Biological Chemistry